rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Arye Weigensberg

Officer

Company insider

Files Form 4 as: Officer, Cronos Group.

In numbers

Trades disclosed
53
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
13 Dec 2022
Last trade
10 May 2026
Last filed
12 May 2026

Companies traded

Where they are an officer
CRON Cronos GroupOfficer · Pharmaceuticals · last 10 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
10 May 2026filed 12 May 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—3,118 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—3,118 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—3,118 at $0.00filing
10 May 2026filed 12 May 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—3,118 at $0.00filing
16 Mar 2026filed 17 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code A—12,245 at $0.00filing
16 Mar 2026filed 17 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code A—12,245 at $0.00filing
15 Mar 2026filed 17 Mar 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—24,236 at $0.00filing
15 Mar 2026filed 17 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—24,236 at $0.00filing
15 Mar 2026filed 17 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—24,236 at $0.00filing
15 Mar 2026filed 17 Mar 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—24,236 at $0.00filing
12 Mar 2026filed 16 Mar 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—26,825 at $0.00filing
12 Mar 2026filed 16 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—26,825 at $0.00filing
12 Mar 2026filed 16 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—26,825 at $0.00filing
12 Mar 2026filed 16 Mar 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—26,825 at $0.00filing
9 Mar 2026filed 10 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code A—63,919 at $0.00filing
9 Mar 2026filed 10 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code A—63,919 at $0.00filing
8 Mar 2026filed 10 Mar 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—21,484 at $0.00filing
8 Mar 2026filed 10 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—21,484 at $0.00filing
8 Mar 2026filed 10 Mar 2026CRON Cronos Groupoption or derivative · PharmaceuticalsSEC FORM 4 Code M—21,484 at $0.00filing
8 Mar 2026filed 10 Mar 2026CRON Cronos GroupPharmaceuticalsSEC FORM 4 Code M—21,484 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Christopher MartensGeneral Manager · General Manager at Cronos Group, filing Form 4 there in the last year
Jason Marc AdlerDirector · Director at Cronos Group, filing Form 4 there in the last year
James Daniel RudykDirector · Director at Cronos Group, filing Form 4 there in the last year
Murray R. GarnickDirector · Director at Cronos Group, filing Form 4 there in the last year
Terrence Gregory Joseph DoucetOfficer · Officer at Cronos Group, filing Form 4 there in the last year